Circulating PD‐L1 in NSCLC patients and the correlation between the level of PD‐L1 expression and the clinical characteristics

Publisher： John Wiley & Sons Inc

E-ISSN： 1759-7714|6|4|534-538

ISSN： 1759-7706

Source： Thoracic Cancer, Vol.6, Iss.4, 2015-07, pp. : 534-538

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

ADAP and SKAP55 deficiency suppresses PD‐1 expression in CD8+ cytotoxic T lymphocytes for enhanced anti‐tumor immunotherapy

By  

EMBO Molecular Medicine, Vol. 7, Iss. 6, 2015-06 ,pp. : 754-769

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pulmonary pleomorphic carcinoma with few PD‐1‐positive immune cells and regulatory T cells that showed a complete response to nivolumab

By  

Thoracic Cancer, Vol. 9, Iss. 1, 2018-01 ,pp. : 193-196

John Wiley & Sons Inc

Access to resources Recommend Favorite

Deficient expression of aldehyde dehydrogenase 1A1 is consistent with increased sensitivity of Gorlin syndrome patients to radiation carcinogenesis

By  

Molecular Carcinogenesis, Vol. 54, Iss. 6, 2015-06 ,pp. : 473-484

John Wiley & Sons Inc

Access to resources Recommend Favorite

Relationship between UGT1A1*27 and UGT1A1*7 polymorphisms and irinotecan‐related toxicities in patients with lung cancer

By  

Thoracic Cancer, Vol. 9, Iss. 1, 2018-01 ,pp. : 51-58

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinicopathological characteristics and outcomes of ROS1‐rearranged patients with lung adenocarcinoma without EGFR, KRAS mutations and ALK rearrangements

By  

Thoracic Cancer, Vol. 6, Iss. 4, 2015-07 ,pp. : 413-420

John Wiley & Sons Inc

Access to resources Recommend Favorite